Pablo Oppezzo
6PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 28, 2025
Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.Angimar Uriepero-Palma, Maria Elena Márquez, Eugenia Payque
|Sep 21, 2022
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo
|Apr 12, 2022
TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.Maria Elena Marquez, Sandra Sernbo, Eugenia Payque
|Jul 22, 2021
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.Pablo Elías Morande, Xiao-Jie Yan, Julieta Sepulveda
|Mar 01, 2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.Pablo Elías Morande, Mariela Sivina, Angimar Uriepero
|Jun 29, 2018
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.Daniel Prieto, Noé Seija, Angimar Uriepero
Pageof 1
Frequent Collaborators
2 joint publications
Daniel Prieto
2 joint publications
Marcelo Navarrete
2 joint publications
Carolina Oliver
1 joint publications
Pablo Fresia
1 joint publications
Xiao-Jie Yan
1 joint publications
Julieta Sepulveda
1 joint publications
Natalia Sotelo
1 joint publications
Gabriel Fernández-Graña
1 joint publications
Stephen P Methot
1 joint publications
Alejandro Buschiazzo
